Boehringer Ingelheim Espana S.A. FDA Record

Summary

Related names

Each name below has its own page. Its counts cover only the records FDA filed under that name and are not part of the totals for Boehringer Ingelheim Espana S.A. above.

Recent FDA inspections

1 inspection on Jun 30, 2023.

NAI

No objectionable conditions or practices were found during the inspection.

VAI

Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.

OAI

Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

Boehringer Ingelheim Espana S.A. and the FDA: common questions

Has Boehringer Ingelheim Espana S.A. received an FDA warning letter?

No FDA warning letter addressed to the name "Boehringer Ingelheim Espana S.A." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Boehringer Ingelheim Espana S.A. received an FDA Form 483?

FDA has not published a Form 483 for "Boehringer Ingelheim Espana S.A." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Boehringer Ingelheim Espana S.A.?

The most recent FDA inspection on file ended Jun 30, 2023 at Sant Cugat Del Valles, Spain and was classified VAI. FDA has 1 inspection of Boehringer Ingelheim Espana S.A. on file.